PRME Q1 2024 Earnings — Prime Medicine, Inc. Revenue & Financial Results | Market Cap Arena

PRMEPrime Medicine, Inc.

$771M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$591,000

Gross Profit

-$724,000-122.5% margin

Operating Income

-$48M-8179.5% margin

Net Income

-$46M-7743.0% margin

EPS (Diluted)

$-0.44

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$68M

Free Cash Flow

-$70M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$311M

Total Liabilities

$68M

Stockholders' Equity

$244M

Cash & Equivalents

$94M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$591,000	$0	—
Gross Profit	-$724,000	$0	—
Operating Income	-$48M	-$40M	-20.8%
Net Income	-$46M	-$39M	-16.2%